Acurx Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 11/13/2024 | 529,349 | $1.01 M | 7.66% | 3.23% |
| PROSPECT FINANCIAL SERVICES LLC | 10/15/2024 | 295,075 | $560,643 | 6.10% | 1.80% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 146,500 | $278,382 | 12.68% | 0.90% |
| MORGAN STANLEY | 11/14/2024 | 46,201 | $87,782 | -0.43% | 0.28% |
| LPL FINANCIAL LLC | 11/08/2024 | 44,780 | $85,082 | -16.67% | 0.27% |
| STATE STREET CORP | 11/14/2024 | 43,466 | $82,585 | 0.00% | 0.27% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 28,535 | $54,217 | 100.00% | 0.17% |
| NBC SECURITIES, INC. | 10/15/2024 | 19,000 | $36,000 | 0.00% | 0.12% |
| TD WATERHOUSE CANADA INC. | 11/12/2024 | 18,656 | $35,633 | 0.00% | 0.11% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 14,210 | $26,999 | -6.57% | 0.09% |
| PATRIOT FINANCIAL GROUP INSURANCE AGENCY, LLC | 10/24/2024 | 10,385 | $19,732 | 0.00% | 0.06% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 11/08/2024 | 10,000 | $19,000 | 0.00% | 0.06% |
| CITADEL ADVISORS LLC | 11/14/2024 | 9,700 | $18,430 | -46.99% | 0.06% |
| CITADEL ADVISORS LLC | 11/14/2024 | 9,200 | $17,480 | -35.21% | 0.06% |
| SEMMAX FINANCIAL ADVISORS INC. | 11/14/2024 | 5,879 | $10,876 | 0.00% | 0.04% |
| CORNERSTONE PLANNING GROUP LLC | 11/05/2024 | 3,344 | $6,487 | 0.00% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 2,065 | $3,924 | -50.10% | 0.01% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 11/12/2024 | 1,636 | $3,108 | 0.00% | 0.01% |
| SIMPLEX TRADING, LLC | 11/08/2024 | 1,161 | $2,000 | -60.21% | 0.01% |
| GPS WEALTH STRATEGIES GROUP, LLC | 10/29/2024 | 500 | $950 | 0.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 11/14/2024 | 173 | $329 | -96.69% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 113 | $215 | 7.62% | 0.00% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 10/28/2024 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
Acurx Pharmaceuticals, Inc.institutional Ownership - FAQ's
During the previous two years, 26 institutional investors and hedge funds held shares of Acurx Pharmaceuticals, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 529,349
Prospect Financial Services LLC: 295,075
GEODE CAPITAL MANAGEMENT, LLC: 146,500
MORGAN STANLEY: 46,201
LPL Financial LLC: 44,780
STATE STREET CORP: 43,466
7.63% of Acurx Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 1.26 M shares in the last 24 months. This purchase volume represents approximately $1.11 M in transactions.